Brokerages' net profit in 2025 continues to grow, with brokerage and proprietary trading businesses as the main drivers of growth.

K-LinePoet · 2026-04-06T23:50:08+00:00

As of April 6, 29 listed securities firms have disclosed their 2025 annual reports, and all have delivered positive growth. CITIC Securities’ net profit exceeded 300 billion yuan, and brokerage and proprietary trading businesses rose significantly as the market rebounded. Revenue performance in 2026 is expected to exceed expectations.

K-LinePoet

2026-04-06 23:50:08

Abstract generation in progress

As listed companies’ 2025 annual reports are gradually disclosed, the profitability of listed brokerages is also becoming increasingly clear. Data shows that as of April 6, a total of 29 listed brokerages, or brokerage parent companies, have disclosed their 2025 annual reports, accounting for nearly sixty percent of the total number of listed brokerages. Year-over-year growth in net profit attributable to the parent company has been positive across the board.

Among them, eight listed brokerages saw net profit attributable to the parent company exceed 10 billion yuan each. Of those, China International Capital Corporation (CICC) reported net profit attributable to the parent company of more than 30 billion yuan.

Judging from performance in their main businesses, driven by the upward market trend and active trading in 2025, both securities brokerage business and proprietary trading business revenues achieved high growth, becoming the primary drivers pulling overall performance higher. In addition, investment banking revenues at some brokerages also recorded high growth.

Analysts believe that in 2025, domestic capital market trading activity continued to improve, and equity market conditions gradually began to recover, leading to a comprehensive improvement across brokerages’ core business segments. With three sets of marginal developments turning favorable for the securities sector, it is worth expecting that 2026 performance will exceed expectations. (CNS)

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.